Articles dans des revues avec comité de lecture (217)
  1. 120. Rozenberg, S., & Gevers, R. (2004). Pro's en contra's van hormoonsubstitutie in het licht van de recente belangrijke epidemiologische studies. Tijdschrift voor fertiliteitsonderzoek, 18(3), 50-53.
  2. 121. Skouby, S. O., Barlow, D., Samsioe, G., Gompel, A., Pines, A., Al-Azzawi, F., Graziottin, A., Hudita, D., Rozenberg, S., & European Menopause and Andropause Society (EMAS), (2004). Climacteric medicine: European Menopause and Andropause Society (EMAS) statements on postmenopausal hormonal therapy. Maturitas, 48(1), 19-25. doi:10.1016/j.maturitas.2004.03.003
  3. 122. Rozenberg, S., Pastijn, A., Gevers, R., & Murillo, D. (2004). Estrogen therapy in older patients with recurrent urinary tract infections: A review. International journal of fertility and women's medicine, 49(2), 71-74.
  4. 123. Antoine, C., Liebens, F., Carly, B., Pastijn, A., & Rozenberg, S. (2004). Influence of HRT on prognostic factors for breast cancer: A systematic review after the Women's Health Initiative trial. Human reproduction, 19(3), 741-756. doi:10.1093/humrep/deh112
  5. 124. Regnard, C., Nosbusch, M., Fellemans, C., Benali, N., Van Rysselberge, M., Barlow, P., & Rozenberg, S. (2004). Cesarean section scar evaluation by saline contrast sonohysterography. Ultrasound in obstetrics & gynecology, 23(3), 289-292. doi:10.1002/uog.999
  6. 125. Bertrand, E., Zissis, G., Marissens, D., Gerard, M., Rozenberg, S., Barlow, P., & Delvigne, A. (2004). Presence of HIV-1 in follicular fluids, flushes and cumulus oophorus cells of HIV-1-seropositive women during assisted-reproduction technology. AIDS, 18(5), 823-825. doi:10.1097/00002030-200403260-00019
  7. 126. Ena, G., & Rozenberg, S. (2003). Issues to debate on the Women's Health Initiative (WHI) study. Prescription attitudes among Belgian gynaecologists after premature discontinuation of the WHI study. Human reproduction, 18(11), 2245-2248. doi:10.1093/humrep/deg457
  8. 127. Delvigne, A., & Rozenberg, S. (2003). Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Human reproduction update, 9(1), 77-96. doi:10.1093/humupd/dmg005
  9. 128. Delvigne, A., Kostyla, K., Murillo, D., Van Hoeck, J., & Rozenberg, S. (2003). Oocyte quality and IVF outcome after coasting to prevent ovarian hyperstimulation syndrome. International journal of fertility and women's medicine, 48(1), 25-31.
  10. 129. Peretz, A., Siderova, V., Body, J.-J., Dumon, J. C., Rozenberg, S., Fellemans, C., Fuss, M., & Bergmann, P. (2003). Response to alendronate in osteoporotic women previously treated with pamidronate. Maturitas, 44(2), 111-115.
  11. 130. Devogelaer, J.-P., Dreiser, R. L., Abadie, E., Avouac, B., Bouvenot, G., Carbonell Abello, J., Kaufman, J.-M., Koes, B. W., Laslop, A., Lemmel, E. M., Richy, F., Rozenberg, S., Tavares, V., Valat, J. P., & Reginster, J.-Y. (2003). Guidelines for clinical studies assessing the efficacy of drugs for the management of acute low back pain. Clinical and Experimental Rheumatology, 21(6), 691-694.
  12. 131. Delvigne, A., & Rozenberg, S. (2002). Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): A review. Human reproduction update, 8(6), 559-577. doi:10.1093/humupd/8.6.559
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Suivant >>